KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 152 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $659,000 | -51.7% | 193,848 | -46.5% | 0.00% | 0.0% |
| Q2 2018 | $1,363,000 | +22.1% | 362,509 | +32.8% | 0.00% | 0.0% |
| Q1 2018 | $1,116,000 | -26.2% | 272,981 | -16.1% | 0.00% | -50.0% |
| Q4 2017 | $1,513,000 | +11.1% | 325,386 | +69.6% | 0.00% | +100.0% |
| Q3 2017 | $1,362,000 | -3.0% | 191,850 | -1.2% | 0.00% | -50.0% |
| Q2 2017 | $1,404,000 | +18.1% | 194,138 | +0.6% | 0.00% | 0.0% |
| Q1 2017 | $1,189,000 | +68.4% | 192,982 | +60.1% | 0.00% | +100.0% |
| Q4 2016 | $706,000 | +460.3% | 120,546 | +408.5% | 0.00% | – |
| Q3 2016 | $126,000 | -26.7% | 23,704 | -8.7% | 0.00% | – |
| Q2 2016 | $172,000 | +49.6% | 25,951 | +5.4% | 0.00% | – |
| Q1 2016 | $115,000 | -12.9% | 24,623 | -5.9% | 0.00% | – |
| Q4 2015 | $132,000 | +78.4% | 26,156 | +24.9% | 0.00% | – |
| Q3 2015 | $74,000 | -85.1% | 20,946 | -57.7% | 0.00% | -100.0% |
| Q2 2015 | $495,000 | -40.5% | 49,562 | -24.1% | 0.00% | -50.0% |
| Q1 2015 | $832,000 | +13.0% | 65,338 | +25.6% | 0.00% | 0.0% |
| Q4 2014 | $736,000 | 0.0% | 52,038 | -2.8% | 0.00% | 0.0% |
| Q3 2014 | $736,000 | -28.6% | 53,552 | -20.1% | 0.00% | 0.0% |
| Q2 2014 | $1,031,000 | -13.9% | 67,019 | -4.6% | 0.00% | -33.3% |
| Q1 2014 | $1,197,000 | +34.3% | 70,245 | +2.1% | 0.00% | +50.0% |
| Q4 2013 | $891,000 | +70.7% | 68,768 | +32.9% | 0.00% | +100.0% |
| Q3 2013 | $522,000 | +96.2% | 51,729 | +45.4% | 0.00% | 0.0% |
| Q2 2013 | $266,000 | – | 35,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |